Related Experiment Video
Updated: May 22, 2026
08:22
Ultrasensitive Detection of Biomarkers by Using a Molecular Imprinting Based Capacitive Biosensor
Published on: February 16, 2018
Fractal gold modified electrode for ultrasensitive thrombin detection
Li-Ping Xu1, Shuqi Wang, Haifeng Dong
1Research Center for Bioengineering and Sensing Technology, University of Science & Technology Beijing, Beijing 100083, China. xuliping@ustb.edu.cn
Nanoscale
|May 25, 2012
Summary
We developed a novel fractal gold electrode (FracAu) for ultrasensitive, label-free thrombin detection. This aptasensor achieves a femtomolar detection limit, showing promise for early disease diagnosis.
Area of Science:
- Electrochemistry
- Biosensor Technology
- Nanomaterials
Background:
- Thrombin is a key biomarker in hemostasis and thrombosis.
- Accurate and sensitive detection of thrombin is crucial for clinical diagnosis.
- Existing biosensors often lack sensitivity or require labeling.
Purpose of the Study:
- To develop a label-free and ultrasensitive aptasensor for thrombin detection.
- To utilize a novel fractal gold modified electrode for enhanced sensing performance.
- To establish a new method for clinical diagnosis of disease-related biomarkers.
Main Methods:
- Fabrication of a fractal gold (FracAu) electrode via electrodeposition on an indium tin oxide (ITO) substrate.
- Immobilization of a thiol-modified aptamer onto the FracAu electrode through self-assembly.
- Detection of thrombin using differential pulse voltammetry (DPV) by measuring changes in electron transfer.
- Characterization of the electrode surface using scanning electron microscopy (SEM).
Main Results:
- The FracAu electrode demonstrated ultrasensitive thrombin detection with a femtomolar limit of detection (5.7 fM).
- A linear relationship was observed between the current response and logarithm of thrombin concentrations (10^-15 to 10^-10 M).
- The aptasensor exhibited high selectivity for thrombin detection.
Conclusions:
- The developed FracAu electrode-based aptasensor offers a highly sensitive and label-free platform for thrombin detection.
- This approach shows significant potential for clinical applications in diagnosing diseases related to thrombin levels.
- The FracAu electrode technology can be extended to develop other types of biosensors.
